In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Poster Pearl: Sacituzumab Govitecan for HR+/HER2- mBC Boosts PFS and OS
Poster Pearl: Sacituzumab Govitecan for HR+/HER2- mBC Boosts PFS and OS
Treating mTNBC: A Safety Analysis of Sacituzumab Govitecan
Treating mTNBC: A Safety Analysis of Sacituzumab Govitecan
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Approaches to Utilizing Bone-targeting Therapies in mBC
Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Diving into the Efficacy & Tolerability of mBC Treatment
Diving into the Efficacy & Tolerability of mBC Treatment
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
